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Abstract
Background: Worldwide, the prevalences of diabetes and dementia are both increasing, particularly in older people.
Rates of diabetes in people with dementia are between 13 and 20 %. Diabetes management and diabetic self-care
may be adversely affected by the presence of dementia. There is a need to know what interventions work best in the
management of diabetes in people living with dementia (PLWD) in different settings and at different stages of the
dementia trajectory. The overall aim is to develop an explanatory account or programme theory about ‘what works’ in
the management of diabetes in people in what context and to identify promising interventions that merit further
evaluation.
Methods/design: This study uses a realist approach including studies on the management of diabetes in older people,
medication management, diabetes-related self-care, workforce issues and assessment and treatment. We will use an
iterative, stakeholder driven, four-stage approach. Phase 1: development of initial programme theory/ies through a first
scoping of the literature and consultation with key stakeholder groups (user/patient representatives, dementia-care
providers, clinicians, diabetes and dementia researchers and diabetes specialists). Phase 2: systematic searches of the
evidence to test and develop the theories identified in phase 1. Phase 3: validation of programme theory/ies with a
purposive sample of participants from phase 1. Phase 4: actionable recommendations for the management of diabetes
in PLWD.
Discussion: A realist synthesis of the evidence will provide a theoretical framework (i.e. an explanation of how
interventions work, for whom, in what context and why) for practice and future research work that articulates
the barriers and facilitators to effective management of diabetes in people with dementia. By providing possible
explanations for the way in which interventions are thought to work and how change is achieved, it will demonstrate
how to tailor an intervention to the setting and patient group. The propositions arising from the review will also inform
the design of future intervention studies.
Systematic review registration: PROSPERO registration number CRD42015020625.
Keywords: Dementia, Diabetes, Realist review
Background and rationale
Dementia and diabetes mellitus are common long-term
conditions and may co-exist in a large number of older
people [1–3]. Worldwide, there are an estimated 35.6
million people with dementia. By 2050, this number will
rise to over 115 million [4]. Although there are differences
in the physical and cognitive effects of the different types
of dementias, all are progressive, involve increasing
physical and mental deterioration and lead to a person
with dementia to become increasingly dependent. Diabetes
mellitus is seen in 10–25 % of older people [5, 6], and in
nursing homes, up to 27 % of residents may have diabetes
[7–9]. As with dementia, the prevalence of type 2 diabetes
is increasing globally [10, 11] and there is evidence to sug-
gest there is a link between cognitive dysfunction and type
2 diabetes [1, 12, 13]. A recent scoping review found data
to suggest that rates of diabetes in people with dementia
are between 13 and 20 % [14].
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Having dementia or cognitive impairment impacts on a
person’s ability to understand their condition and under-
take self-care management tasks such as managing medi-
cation and monitoring blood glucose [3, 15–17] and is
associated with an increased use of both health and social
services [17]. Moreover, people with dementia are at
greater risk of hypoglycaemia than older people without
dementia [18–21] and may be at risk of drug interactions
and adverse reactions due to polypharmacy [22]. There is
also evidence that people with dementia may have poorer
access to diabetes services and monitoring than people
without dementia [23–26].
There is currently no systematic approach to the man-
agement of diabetes and dementia [27], and most care
pathways for diabetes do not take into account the needs
of people with dementia [28]. Clinical guidance on the
management of diabetes in older adults [22, 29–31] sug-
gests that glycaemic targets should be individualised for
older people and take into account factors such as age, de-
mentia, frailty, comorbidities and polypharmacy [32, 33].
However, there is limited evidence on the outcomes of
such approaches for people with dementia [34].
The main approach to the management of long-term
conditions such as diabetes revolves around self-
management strategies focusing on the attitudes and
self-efficacy of the patient, for example, using motiv-
ational interventions [35] or education programmes
[36, 37]. Whilst this may be appropriate in the earlier
stages of dementia [38], capacity for self-management
will diminish as the dementia progresses and interven-
tions may instead have to target family carers. The situ-
ation is further complicated in that management may
differ for those whose diabetes pre-dates a diagnosis of
dementia compared to patients who develop diabetes
post-dementia. There are additional difficulties related to
insulin management. Interviews conducted as part of a re-
cent National Institute for Health Research (NIHR) study
suggest that as people living with dementia become un-
able to manage their own medication, they find injections
distressing and painful [39]. They may also forget to eat or
take medication leading to episodes of hypoglycaemia and
in some instances hospitalisation [39].
Physical frailty [33] or end-stage dementia compound
the complexity of diabetes management, with decisions
needing to be made about whether to maintain treat-
ment or consider admission into nursing home care
[40]. The underlying assumption of this proposal is that
the effectiveness of programmes to manage diabetes in
people with dementia is contingent not only on specific
diabetes-focused interventions but also on contextually
situated decision-making. Interventions designed to im-
prove the management of diabetes in people with demen-
tia are likely to be multi-component, specific to different
stages of the dementia trajectory and dependent on the
behaviours and choices of those delivering and receiving
the care.
To develop a theoretical understanding of the realities of
working in and across complex, overlapping systems of care
and why and how different interventions may work, there
is a need to synthesise the different strands of research evi-
dence. Realist synthesis is a systematic, theory-driven ap-
proach that aims to make explicit the mechanism(s) of how
and why complex interventions are effective (or not) in par-
ticular settings [41–45]. Realist synthesis takes account of a
broad evidence base as well as the experiential and clinical
knowledge that relates to the physiology and management
of diabetes in older people and specifically older people
with dementia. Evidence of interest would include evalua-
tions of interventions relating to glycaemic control in older
people, medication management, diabetes-related self-care
and those that address system-wide issues about access
to assessment and treatment. It would also include
those that, by association, have the potential to improve
diabetes care for people with dementia (for example,
studies on relationship-centred care, interventions to
individualise or target care for people with dementia
and the development and implementation of interventions).
Realist synthesis methodology will enable us to deconstruct
the component theories underpinning different interven-
tions aimed at people with dementia and/or diabetes and to
consider relevant contextual data to test our understanding
of the applicability of different approaches for this popula-
tion and in different settings.
Methods
We will use an iterative four-stage approach that opti-
mises the knowledge and networks of the research team.
The review is based on the stages set out by Pawson
et al. [46] and follows the RAMESES publication
standards [45]. The objectives are to
1. Identify how interventions, or elements of
interventions, to manage diabetes in people with
dementia are thought to work, on what range of
outcomes (i.e. organisational, resource use and
patient care and safety) and for whom they work
(or why they do not work) and in what context
2. Identify the barriers and facilitators to the
acceptability, uptake and implementation of
interventions designed to manage diabetes in
people with dementia
3. Establish what evidence there is on the feasibility
and potential value of interventions to manage
diabetes in people with dementia
4. Establish what is known about the design of diabetes
management technologies and identify the potential
benefits of involving end users (people with
dementia and their carers) in their development.
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Ethics
Ethical approval for the stakeholder interviews has been
obtained from the University of Hertfordshire Health and
Human Sciences Ethics Committee with delegated author-
ity (ECDA), reference number cHSK/SF/UH/00106.
A PRISMA-P file is attached (Additional file 1).
Realist approach
Within this review, the purpose is to develop an explana-
tory account or programme theory about ‘what works’ in
the management of diabetes in people with dementia, and
in what context. Explanatory accounts comprise configura-
tions of context (the contingencies on which programme
changes are dependent), mechanism (the changes that are
brought about through a programme) and outcomes
(programme impacts). These configurations are developed
iteratively through data collection, theorising and stake-
holder engagement.
We are working on the assumption that a review on the
management of diabetes in people with dementia has to
consider complementary evidence. For example, evidence
on the effectiveness of interventions to improve diabetes
management in older people without dementia, interven-
tions to improve the health and well-being of people with
dementia and studies that rely on healthcare professionals
in different settings working together, and with family
carers, to improve diabetes management for older people.
It is likely that the review will be informed by theoretical
work on the following:
 Management of diabetes in older adults and those
with complex health needs (including issues such as
individualising glycaemic targets for people with
dementia, glycaemic targets that take into account
the risk and impacts of hypoglycaemia in this group)
[29, 30, 46, 47]
 Patient-centred approaches to glycaemic
management in people with diabetes that balance
treatment targets against quality of life and patient
and carer preferences [48, 49] and that involve
patients and carers in the development of
interventions
 Theories about the way services are designed,
delivered or implemented for people with dementia,
e.g. work that clinical staff do in tailoring or co-
constructing interventions to individuals, including
case management approaches, shared care models
and assistive technology [50]
 Theories around diagnostic or clinical
overshadowing—for example, if the dementia is
associated with behaviours that are challenging (e.g.
aggression, agitation, psychosis) then dementia may
become clinically dominant and detract from the
management of conditions such as diabetes [51, 52]
 Interventions that provide education or support for
the family carers of people with dementia to help
them cope with the behavioural, psychological and
emotional consequences of dementia [53–58]
 Theories on the provision of person-centred/relation-
ship-centred care for people with dementia [59–62].
Phase 1: defining the scope of the review: concept
mining and theory development
The project team will draw on their collective experience
in diabetes, dementia, older people’s health and realist
methods to develop initial programme theories about dia-
betes management interventions. Programme theories are
possible explanations for the way in which particular inter-
ventions are thought to work, and they describe the way in
which change occurs because of an intervention [63].
We will undertake a preliminary scoping of a selection
of key literature (e.g. relevant evaluations of interven-
tions for people with dementia or interventions for frail
older people with diabetes). References collated by the
project team for recent work on diabetes and dementia
[14, 27, 31] will be supplemented by key word searches,
discussion with the wider project team and interviews or
focus groups with stakeholders. The following key stake-
holder groups have been identified:
1. Clinicians with a special interest in the management
of diabetes in older people,
2. Providers of care in primary and secondary care (e.g.
diabetes specialist nurses, GPs and other clinicians),
3. User representatives including recipients of care and
their family carers and relevant diabetes or dementia
charities
4. Academics and those involved in developing
education and guidance for older people with diabetes
5. Dementia specialists from primary, secondary and
tertiary care and the voluntary sector (e.g. old age
psychiatrists, dementia specialist nurses and GPs
with an interest in dementia).
Stakeholder interviews will be conducted using a topic
guide and, with permission, digitally recorded.
This will be followed by a 1-day workshop where the
project team will begin to identify common concepts
and map and prioritise the theory identified from the
searches and consultation. The process will also draw
on the existing research and clinical experience of the
research team and project advisory group. To ensure
transparency of approach, and an audit trail, we will
record group discussions and maintain structured field
notes on suggestions and decision-making processes
about which sources of evidence were linked to which
strands of theoretical development [42]. An output
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from phase 1 will be a theoretical/conceptual frame-
work, and associated candidate programme theories,
that will inform the review process.
Phase 2: retrieval, review and synthesis
First, we will target evidence relevant to the manage-
ment of diabetes in people living with dementia. This
will include interventions that address the knowledge
and skills required to promote effective diabetes care
and specific interventions to manage diabetes in people
with dementia or cognitive impairment (including those
that focus on family carers). However, previous and
current work by the project team suggests that there are
few studies that look specifically at the management of
diabetes in people with dementia or that evaluate inter-
ventions designed specifically for this population. Realist
synthesis enables the testing of the relevance and rigour
of emerging findings from one body of literature to
another, and in line with the iterative nature of realist
synthesis methodology [64], the inclusion criteria will
be refined in light of emerging data and the theoretical
development in phase 1.
The review is likely to include evidence sources that
cover the following:
 People with mild, moderate or advanced dementia
(of any type, e.g. Alzheimer’s disease, vascular
dementia, Lewy body dementia, Parkinson’s
disease dementia, fronto-temporal dementia and
alcohol-related dementia) and type 1 or type 2 diabetes,
resident in the community or a care home or other
long-term setting, or who are being treated in hospital.
 Studies of any intervention designed to promote the
management of diabetes in people with dementia and
the prevention of potential adverse effects associated
with poorly managed diabetes such as falls, blindness,
vascular complications or renal failure.
 Studies that provide evidence on barriers and
facilitators to the implementation and uptake of
interventions designed to improve the physical
health of people with dementia (e.g. dementia-friendly
initiatives, the impact of the cognitive versus
behavioural and psychological symptoms of
dementia and the progression of dementia on
family carers and service providers).
 Studies that offer opportunities for transferable
learning such as those that evaluate interventions
for people with dementia and other clinical
conditions, or those that look at the way services
are delivered and implemented for people with
dementia (for example, interventions to: improve
access or continuity, tailor care to the needs of
individuals with dementia or support family
carers).
Outcomes
Outcomes will be established by the project team in an
iterative process but are likely to include the following:
 Health and well-being of older people with diabetes
and dementia and their family carers, e.g.
 Glycaemic management and the prevention of
hypoglycaemia and hyperglycaemia
 Management of cardiovascular risk factors such
as hypertension and hyperlipidemia
 Identification, management and prevention of
long-term complications such as depression, vis-
ual problems and neuropathic complications [28]
 Medication adherence
 Knowledge and quality of life for older people
with dementia and their family carers.
 Outcomes related to service use, e.g. unplanned
hospital admissions.
 Process-related outcomes, e.g. quality of care and
‘what works’ in terms of designing and tailoring
diabetes management technologies.
Types of studies
A diversity of evidence provides an opportunity for richer
data mining and theory development. Therefore, we will
include studies of any design including randomised con-
trolled trials, controlled studies, uncontrolled studies,
interrupted time series studies (ITS), cost effectiveness
studies, process evaluations, surveys and qualitative stud-
ies of participants’ views and experiences of interventions.
We will also include unpublished and grey literature, pol-
icy documents and information about locally implemented
programmes in the UK.
Searching for relevant studies
We will develop search strategies in the following areas: (1)
dementia and diabetes (focusing on issues relating to man-
agement), (2) diabetes management in older adults and
those with multimorbidity, (3) interventions to support
people with dementia and comorbid health conditions (all
conditions not just diabetes) and (4) interventions that in-
volve the family carers of people with dementia. The search
will be iterative, and search areas will be revised as the
review progresses.
In conjunction with an information scientist, the pro-
ject team will develop a list of relevant search terms to
use in the following electronic databases: MEDLINE
(PubMed), CINAHL (Cumulative Index to Nursing &
Allied Health Literature), Scopus, Cochrane Library (in-
cluding the Cochrane Database of Systematic Reviews,
Database of Abstracts of Reviews of Effects (DARE)), the
HTA Database, NHS Economic Evaluation Database
(NHS EED), AgeInfo (Centre for policy on Ageing—UK),
OpenGrey, Social Care Online, the National Research
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Register Archive, the National Institute of Health Re-
search portfolio database, NHS Evidence and Google
Scholar.
Dementia reviews undertaken by members of the project
team [65, 66] have highlighted the importance of lateral
searching for identifying studies in this area. Therefore, in
addition to the above electronic database searches, we will
undertake the following:
 Check reference lists from primary studies and
systematic reviews [67]
 Perform citation searches using the ‘Cited by’ option
on Google Scholar and Scopus, and the ‘Related
articles’ option on PubMed [68]
 Contact experts and those with an interest in
dementia to uncover grey literature (e.g. DeNDRoN,
National Library for Health Later Life Specialist
Library, Alzheimer’s Society and For Dementia)
 Contact diabetes-specific charities and user groups
(Diabetes UK, TREND)
Search results will be downloaded into bibliographic
software and, where possible, duplicates deleted. Two
reviewers will independently screen titles and abstracts
for relevance.
Review
Screening and data extraction
Two reviewers will screen full manuscripts for inclusion
based on the relevance and rigour of the evidence, with
disagreements resolved by discussion with a third author.
Relevance is defined as the extent to which it can contrib-
ute to theory building and/or testing and rigour the extent
to which the methods used to generate that particular
piece of data are credible and trustworthy [41, 45]. For
studies that meet the test of relevance, data will be ex-
tracted onto bespoke data extraction forms which will en-
able us to populate the evidence on context mechanism
outcome configurations [44]. The data extraction form
will be informed by programme theories that emerge from
phase 1 and will be pre-tested by the review team [44].
Data will be extracted by one reviewer and checked by a
second.
Synthesis
The analytical task is in synthesising, across the extracted
information, the relationships between mechanisms (e.g.
changes in reasoning or resources), contexts (e.g. condi-
tions, types of setting, organisational configurations) and
outcomes (i.e. intended and unintended consequences
and impact). Rycroft-Malone et al. [44] have developed an
approach to synthesis, incorporating the work of Pawson
[41] and principles of realist enquiry that includes the
following:
1. Organisation of extracted information into evidence
tables representing the different bodies of literature
(e.g. diabetes management, dementia, health care,
organisation of services, technology)
2. Theming across the evidence tables in relation to
emerging patterns (demi-regularities in realist
literature) amongst context, mechanism and
outcomes (C-M-Os), seeking confirming and
disconfirming evidence within studies and across the
body of evidence as a whole.
3. Linking these demi-regularities (patterns) to refine
hypotheses.
Data synthesis will involve individual reflection and
team discussion and will (1) question the integrity of each
theory, (2) adjudicate between competing theories, (3)
consider the same theory in different settings and (4) com-
pare the stated theory with actual practice. Data from the
studies will then be used to confirm, refute or refine the
candidate theories. If our theories fail to explain the data,
we will seek alternative theories.
Once the preliminary mapping of the evidence is
complete, we will hold a second 1-day workshop with the
research team. This workshop will be structured to in-
clude in-depth discussion of the findings and to develop
and confirm the resultant hypotheses. These will act as
synthesised statements of findings around which we can
develop a narrative that summarises the nature of the con-
text, mechanism and outcome links, and the characteris-
tics of the evidence underpinning them.
The transparency of a realist review synthesis is reliant
on careful documentation of the reasoning processes,
how they are grounded in the evidence and justification
of inferential shifts through engagement with different
evidence sources [42]. This aspect of the review process
is resource intensive and reliant on discussion and de-
liberation, across and with particular members of the
research team. Outputs from phase 2 will include a
comprehensive evidence base related to programmes
designed to manage diabetes in people with dementia
and a set of hypotheses supported by relevant evidence
to be refined in phase 3.
Phase 3: test and refine programme theory/ies (validation)
To develop a final review narrative that addresses what is
necessary for the effective implementation of programmes
to manage diabetes in people with dementia, we will re-
view the hypotheses and supporting evidence through
telephone interviews with up to 15 stakeholders. Partici-
pants will be purposively sampled to ensure that all the
key stakeholder groups in phase 1 are represented. A topic
guide will be developed that aims to elicit stakeholder’s
views on the resonance of the findings, both from a practice
and a service user perspective.
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Phase 4: actionable recommendations
We will work with the project advisory group and com-
missioners and providers, e.g. CCG representatives and
diabetes and dementia experts, to develop a set of ac-
tionable recommendations designed to inform practice
and the development of future research studies. This will
include the development of an evidence informed frame-
work of what works for whom and in what context in
relation to programmes to manage diabetes in people
with dementia, and recommendations for promising in-
terventions for future evaluation.
Discussion
Dementia and diabetes mellitus are common long-term
conditions and may co-exist in a large number of older
people [1–3]. People with dementia may be less able to
understand and manage their diabetes [3, 16, 17] and may
be at risk of complications such as hypoglycaemic epi-
sodes, cardiovascular conditions and amputations which
place a huge burden on health and social care economies
[69]. Moreover the impact of diabetes and dementia on
patients and their families is considerable. A realist syn-
thesis of the evidence will provide a theoretical framework
(i.e. an explanation of how interventions work, for whom,
in what context and why) for practice and future research
work that articulates the barriers and facilitators to effect-
ive management of diabetes in people with dementia. By
providing possible explanations for the way in which inter-
ventions are thought to work and how change is achieved,
it will demonstrate how to tailor an intervention to the
setting and patient group. The propositions arising from
the review will also inform the design of future interven-
tion studies.
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